These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35446012)

  • 1. Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.
    Zupin L; Fontana F; Clemente L; Ruscio M; Crovella S
    Braz J Microbiol; 2022 Sep; 53(3):1271-1277. PubMed ID: 35446012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
    Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
    J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus.
    Klajmon A; Olechowska-Jarząb A; Salamon D; Sroka-Oleksiak A; Brzychczy-Włoch M; Gosiewski T
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
    Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort.
    Kirby JE; Riedel S; Dutta S; Arnaout R; Cheng A; Ditelberg S; Hamel DJ; Chang CA; Kanki PJ
    Clin Microbiol Infect; 2023 Jan; 29(1):94-100. PubMed ID: 35863629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
    Flinck H; Aittoniemi J
    J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid Testing.
    Peck Palmer O; Hasskamp JH; La HS; Pramod Patwardhan P; Ghumman S; Baloda V; Jung Y; Wheeler SE
    Lab Med; 2023 Mar; 54(2):e54-e57. PubMed ID: 36065160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2.
    Kepka Z; Briksi A; Hubáček P; Zajac M; Dřevínek P
    Epidemiol Mikrobiol Imunol; 2023; 72(1):3-8. PubMed ID: 37185021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests.
    Kahn M; Schuierer L; Bartenschlager C; Zellmer S; Frey R; Freitag M; Dhillon C; Heier M; Ebigbo A; Denzel C; Temizel S; Messmann H; Wehler M; Hoffmann R; Kling E; Römmele C
    BMC Infect Dis; 2021 Aug; 21(1):798. PubMed ID: 34376187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
    Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects.
    Stokes W; Berenger BM; Venner AA; Deslandes V; Shaw JLV
    Expert Rev Mol Diagn; 2022 Aug; 22(8):797-809. PubMed ID: 36093682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of rapid antigen testing for the detection of SARS-CoV-2 infection].
    Li JJ; Zeng M; Xu J; Ge YL; Tian H; Wang ZL; Liu GB; Zhai XW; Zhang XB; Zhu QR; Chang HL
    Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1153-1157. PubMed ID: 36319149
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen-Based Point of Care Testing (POCT) for Diagnosing SARS-CoV-2: Assessing Performance.
    Keshav V; Scott L; David A; Noble L; Mayne E; Stevens W
    Methods Mol Biol; 2022; 2452():45-62. PubMed ID: 35554900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Results of Nucleic Acid Amplification Tests for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in Patients with COVID-19.
    Motohashi A; Yamamoto K; Mezaki K; Moriya A; Kurokawa M; Oki H; Ando H; Isaka E; Usami A; Ide S; Nakamura K; Nakamoto T; Nomoto H; Ohmagari N
    Jpn J Infect Dis; 2022 May; 75(3):309-313. PubMed ID: 34588366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.
    Delgado-Diaz DJ; Sakthivel D; Nguyen HHT; Farrokzhad K; Hopper W; Narh CA; Richards JS
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.
    Pray IW; Ford L; Cole D; Lee C; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie D; Cherney B; Kirby M; Fajardo G; Caudill M; Langolf K; Kahrs J; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker P; Folster J; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard R; Killerby M;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1642-1647. PubMed ID: 33382679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.